Lv1
50 积分 2025-03-20 加入
ELABELA衍生肽ELA13通过抑制Smad和ERK信号通路减轻肾纤维化
2个月前
已完结
Update on the pathophysiology and treatment of primary Sjögren syndrome
3个月前
已完结
Dietary-timing-induced gut microbiota diurnal oscillations modulate inflammatory rhythms in rheumatoid arthritis
6个月前
已完结
The gut microbiome as a potential therapeutic target in IgA nephropathy
6个月前
已完结
Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trial
6个月前
已完结
Efficacy and Safety of Nefecon in Patients with Immunoglobulin A Nephropathy from Mainland China: 2-Year NefIgArd Trial Results
6个月前
已完结
Successful pregnancy in a patient with IgA nephropathy treated with telitacicept: a case report
7个月前
已关闭
Role of telitacicept in the treatment of IgA nephropathy
7个月前
已完结
Synbiotics as a novel therapeutic approach for hyperphosphatemia and hyperparathyroidism in chronic kidney disease rats
7个月前
已关闭
Expansion of Escherichia-Shigella in Gut Is Associated with the Onset and Response to Immunosuppressive Therapy of IgA Nephropathy
7个月前
已完结
皖公网安备34019202002308
